Active Ingredient: UMECLIDINIUM BROMIDE
Proprietary Name: INCRUSE ELLIPTA
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: EQ 0.0625MG BASE/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N205382
Product Number: 001
Approval Date: Apr 30, 2014
Applicant Holder Full Name: GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE
Marketing Status:
Prescription
Patent and Exclusivity Information
